z-logo
open-access-imgOpen Access
New drugs for the management of relapsed or refractory diffuse large B-cell lymphoma
Author(s) -
Clémentine Sarkozy,
Laurie H. Sehn
Publication year - 2019
Publication title -
annals of lymphoma
Language(s) - English
Resource type - Journals
ISSN - 2616-2695
DOI - 10.21037/aol.2019.09.01
Subject(s) - medicine , chimeric antigen receptor , oncology , refractory (planetary science) , diffuse large b cell lymphoma , lymphoma , brentuximab vedotin , population , chemotherapy , immunotherapy , cancer , cd30 , physics , environmental health , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom